Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Enzyme Assay from US Patent US11884671: "Purinone compounds and their use in treating cancer"
Assay data:51 Tested
SummaryRelated BioAssays by DepositorRelated BioAssays by Target
Assay data:1 Active, 51 Tested
SummaryCompounds, ActiveRelated BioAssays by DepositorRelated BioAssays by Target
HPK1 Kinase Assay (Biochemical Assay) from US Patent US20240025922: "TETRAHYDROPYRIDO[3,4-d]PYRIMIDINES AS HPK1 INHIBITORS"
Assay data:181 Active, 187 Activity ≤ 1 µM, 187 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMRelated BioAssays by Target
Inhibitory Activity of the Compounds of the Invention Against ROS1, NTRK and ALK and their Drug-Resistant Kinases from US Patent US20240025908: "COMPOUND USED AS KINASE INHIBITOR AND USE THEREOF"
Assay data:29 Active, 14 Activity ≤ 1 nM, 29 Activity ≤ 1 µM, 29 Tested
Measurement of Human IRAK-4 Inhibitory Activity from US Patent US20240025893: "PYRIMIDINE-AND NITROGEN-CONTAINING BICYCLIC COMPOUND"
Assay data:248 Active, 20 Activity ≤ 1 nM, 248 Activity ≤ 1 µM, 248 Tested
HTRF Assay from US Patent US20240018153: "BENZENESULFONAMIDE DERIVATIVES AND USES THEREOF"
Assay data:10 Active, 10 Activity ≤ 1 µM, 10 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMRelated BioAssays by DepositorRelated BioAssays by Target
Assay data:11 Active, 11 Activity ≤ 1 µM, 11 Tested
Assay data:9 Active, 9 Activity ≤ 1 µM, 9 Tested
In Vitro Kinase Detection Assay from US Patent US20240018147: "SALT OF COMPOUND FOR DEGRADING BTK, CRYSTAL FORM THEREOF, AND USE THEREOF IN MEDICINE"
Assay data:1 Active, 1 Activity ≤ 1 µM, 1 Tested
Biochemical Assay for Inhibitors of CK2α Kinase Activity Assay from US Patent US11866436: "Benzo[c][2,6]naphthyridine derivatives, compositions and therapeutic uses thereof"
Assay data:181 Active, 118 Activity ≤ 1 nM, 181 Activity ≤ 1 µM, 181 Tested
Potency of IRAK4 Inhibitor Compounds in IRAK4 Enzyme Assay from US Patent US11866405: "Substituted indazoles as IRAK4 inhibitors"
Assay data:106 Active, 58 Activity ≤ 1 nM, 106 Activity ≤ 1 µM, 107 Tested
In Vitro Activity Assay of JAK1, JAK2, JAK3, TYK2 Kinases from US Patent US20240002404: "SALT OF PYRROLOPYRIMIDINE COMPOUND, CRYSTALLINE FORM THEREOF, AND APPLICATION THEREOF"
Assay for In Vitro Inhibitory Activity Against HPK1 Kinase from US Patent US20240002394: "DEUTERIUM-MODIFIED THIENOPYRIDONE COMPOUND"
IC50 value on BTK wt/C481S Kinase Inhibition from US Patent US20240002387: "METHOD FOR PREPARING BTK DEGRADING AGENT"
BTK Enzyme Activity Assay from US Patent US20240002377: "PYRROLOPYRIDINE COMPOUND AND APPLICATION THEREOF"
Assay data:5 Active, 5 Activity ≤ 1 µM, 5 Tested
p-Cl-ANS Fluorescent Binding Assay from US Patent US20240002339: "THERAPEUTIC COMPOUNDS AND METHODS"
Assay data:11 Active, 5 Activity ≤ 1 µM, 11 Tested
Surface Plasmon Resonance (SPR) from US Patent US20240002339: "THERAPEUTIC COMPOUNDS AND METHODS"
Assay data:20 Active, 7 Activity ≤ 1 µM, 29 Tested
Isothermal Titration Calorimetry (ITC) from US Patent US20240002339: "THERAPEUTIC COMPOUNDS AND METHODS"
Assay data:54 Active, 27 Activity ≤ 1 µM, 83 Tested
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on